News
 
Email Page
On March 17, 2011, Chad Landmon Discussed Bioequivalence at ACI's FDA Boot Camp
March 17, 2011

On March 17, 2011, the American Conference Institute hosted its FDA Boot Camp in New York. Chad Landmon, Chair of the FDA Practice Group at Axinn, gave a presentation focusing on bioequivalence issues and their impact on FDA approval of generic products and Paragraph IV patent litigation. A copy of Chad's presentation can be viewed here:

March_2011_FDA_Boot_Camp_Bioequivalence_Presentation.PPT